Bacterial Antigen Ingredients TRIZ Cases

Selected bacterial antigens and toxoid support maternal immunity while limiting interference in one vaccine.

Sequence alignment and machine learning predict MHC-binding peptides across strains, supporting targeted vaccines and diagnostics.

This case uses solvent killing, rehydration, and size-fractionation to identify immunogens for serotype-independent pneumococcal protection.

Non-covalent complexes pair biotinylated pneumococcal polysaccharides with fusion proteins for broad, durable T- and B-cell responses.

MHC class II peptidomics trains a neural network to predict ranked immunodominant epitopes from pathogen genome sequences.

This case uses an attenuated Salmonella Typhimurium vector to deliver four H. pylori antigens and strengthen mucosal immunity.

This case uses attenuated K6067 and K4110 strains to induce immunity in chickens and turkeys while reducing reliance on antibiotics.

This case uses 8–18 amino acid M. tuberculosis peptides to detect T-cell responses and distinguish latent from active infection.

This case combines multi-epitope Borrelia peptides, encoding nucleic acids, and sonicate vaccine protection.

Aluminum salt plus CpG oligonucleotide strengthens Y. pestis immunity and shortens the vaccination regimen.

Enriched lysates transfer bacterial glycans to carrier proteins, enabling rapid vaccine synthesis and lyophilized production.

Akkermansia and Parabacteroides probiotics mimic ketogenic diet benefits for seizure control.

Affinity-linked TB antigens and polysaccharides support humoral and cellular responses, including improved protection against pulmonary TB.

A polyvalent vaccine combines purified surface proteins from three bacteria with an adjuvant to reduce dairy mastitis.

A multi-antigen Borrelia immunoassay targets IgG and IgM to improve early Lyme detection across serum and cerebrospinal fluid.

Recombinant cells use PglB variants to make homogeneous O-antigen bioconjugates, including glucosylated O4, for ExPEC vaccination.

This vaccine composition uses bacterial membrane vesicles to elicit opsonophagocytic antibodies against diverse pneumococcal strains.

This case pairs cell-based adjuvants with recombinant viral vaccines to activate antigen-presenting cells and improve gene transfer.

Chemical tetrasaccharide conjugates support Burkholderia vaccines and rapid antibody diagnosis.

This case uses mutated Bordetella BPZE1 to reduce IL-17 inflammation and help preserve lung function in COPD.

LDAO shortens azide-alkyne conjugation from days to hours while preserving yield and selectivity for biomolecular coupling.

This vaccine approach uses lipidated toxin B polypeptides and controlled production to preserve structure and strengthen CDI protection.

This case uses attenuated aroA-mutant Bordetella strains for oral vaccines, reducing administration burden and adjuvant-related reactions.

This case uses dominant outer membrane protein peptides to detect Anaplasma antibodies and distinguish infecting species.

Mycobacterium tuberculosis antigen combinations support immunogenicity and help distinguish BCG vaccination from infection in diagnosis.

CRBD-MTT combines a SARS-CoV-2 receptor-binding domain with modified tetanus toxin to elicit neutralizing antibodies with reduced toxicity.

This case addresses uncertain vaccine stability with an engineered live attenuated strain and stabilizer blend for storage.

Controlled oxidation, quenching, and reduction prepare conjugates targeting pneumococcal serotypes 10A, 22F, and 33F.

This vaccine case removes a TcdB2 region to limit toxicity while retaining glucosylation and neutralizing antibody responses.

Recombinant VapA and VapC peptides induce protective antibodies against Rhodococcus equi, reducing antibiotic reliance.

Chimeric antigens induce antibodies that bind internal larval proteins, reducing pathogenic burden without selecting for drug resistance.

Identifying this pathogen resolves unclear mechanisms of bacterial translocation, enabling precise diagnostic prediction for primary sclerosing cholangitis.

Light scattering instruments measure average molecular weight to ensure consistent distribution for vaccine production.

Removing accessory proteins from botulinum toxin eliminates gastric resistance, preventing systemic poisoning while maintaining local efficacy.

Recombinant antigen mixtures in lateral flow assays detect TB antibodies, reducing false negatives from skin test limitations.

Liquid diphtheria-tetanus-pertussis antigen solution reconstitutes a lyophilised meningococcal component into a single combined vaccine dose.

Immunogenic vaccine composition targets specific Mycobacterium paratuberculosis genes to stimulate protective immune responses in mammals.

Administering Oribacterium sp. JBO3-101 and Ruminococcus sp. JBR5-501 establishes a protective gut microbiome in experimental animals.

Protein-based pneumococcal antigens elicit serotype-independent immunity, reducing production costs while preventing serotype replacement.

Regulated delayed in vivo shut off of virulence genes enables biological containment while inducing robust protective immunity against Brucella infection.

Immunological Response Shifters combine pathogen and danger signals with antibiotics to reprogram host immune defenses.